Skip to content

Optimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations.

Optimising CMR Scan Acquisitions for Novel Equipment/Sequences in Clinical Cardiovascular Populations.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06311552
Acronym
OPTMISE-HFpEF
Enrollment
30
Registered
2024-03-15
Start date
2022-01-31
Completion date
2023-11-30
Last updated
2024-03-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure With Preserved Ejection Fraction

Brief summary

The purpose of this study is to develop robust protocols for the optimisation of novel hardware, software and exercise equipment in the magnetic resonance imaging (MRI) environment in various cohorts with cardiovascular disease (CVD) with the first study focusing on those with established heart failure with preserved ejection fraction (HFpEF) or those at risk of or with pre-HFpEF.

Interventions

OTHERParticipants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner

Participants will undergo a comprehensive CMR scan on either a 1.5- or 3-Tesla scanner

Sponsors

University of Leicester
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Males or females aged \>18 years * Either a clinical diagnosis of HFpEF, be at risk of or pre- HFpEF

Exclusion criteria

* Absolute contraindication to MRI * Unable to read/understand English sufficiently to provide informed consent * Pregnancy * Unable to consent due to lack of mental capacity * Current cancer diagnosis and actively undergoing treatment * Inability to exercise on the MRI ergometer * Severe claustrophobia

Design outcomes

Primary

MeasureTime frame
To develop CMR scanning protocols which acquire the highest quality images during incremental exercise using a stepper ergometer (Ergospect Cardio-stepper).By end of study - 30/04/2023

Secondary

MeasureTime frame
To determine the reproducibility of the exercise CMR protocols in a test-retest reproducibility sub-studyBy end of study - 30/04/2023
To determine the optimal scan acquisition protocol for Magnetic Resonance Spectroscopy (MRS) both H+ and 31P using the phosphorous coil in each patient group.By end of study - 30/04/2023
To determine the reproducibility of the MRS protocols in a test-retest reproducibility sub-studyBy end of study - 30/04/2023

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026